To include your compound in the COVID-19 Resource Center, submit it here.
Allergan will acquire Kythera for about $2.1 billion in a cash and stock deal. Kythera shareholders will
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury